Clinical classification of dopaminergic effects in parkinsonism.
Schering AG Berlin, Fed. Rep. Germany.
R
R
Horowski
I
I
Runge
D015259:Dopamine Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D015259:Dopamine Agents; D018491:Dopamine Agonists; D007980:Levodopa